Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
暂无分享,去创建一个
Jianjun Cheng | Kaimin Cai | Chen Jiang | Yujie Zhang | Xinli Chen | Qinjun Chen | Qin Guo | Yifei Lu | Chao Li | Yu Zhang | Tao Sun | Lisha Liu | Xi He | Chunhui Ruan
[1] C. Li,et al. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy , 2018, Theranostics.
[2] Xiaoyuan Chen,et al. Polymeric Nanoparticles with a Glutathione-Sensitive Heterodimeric Multifunctional Prodrug for In Vivo Drug Monitoring and Synergistic Cancer Therapy. , 2018, Angewandte Chemie.
[3] Robert J. Ono,et al. Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery. , 2018, ACS applied materials & interfaces.
[4] Chen Jiang,et al. Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy , 2018, Advanced science.
[5] M. Mandal,et al. Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells. , 2018, ACS applied materials & interfaces.
[6] Min Lin,et al. Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles. , 2018, ACS applied materials & interfaces.
[7] Lin Zhu,et al. Building Stable MMP2-Responsive Multifunctional Polymeric Micelles by an All-in-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery. , 2017, ACS applied materials & interfaces.
[8] Xiaoyuan Chen,et al. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy. , 2017, ACS nano.
[9] Chen Jiang,et al. ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer. , 2017, ACS applied materials & interfaces.
[10] Chen Jiang,et al. Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers. , 2017, ACS applied materials & interfaces.
[11] Qiang Sun,et al. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo. , 2016, Biomaterials.
[12] L. Dobrucki,et al. Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis , 2016, Proceedings of the National Academy of Sciences.
[13] C. Chiu,et al. Distinct CPT-induced deaths in lung cancer cells caused by clathrin-mediated internalization of CP micelles. , 2016, Nanoscale.
[14] Peijun Zhang,et al. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. , 2015, Biomaterials.
[15] Jonathan Yen,et al. Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics. , 2015, Biomaterials science.
[16] Wim E Hennink,et al. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. , 2015, ACS nano.
[17] N. Zaffaroni,et al. PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins , 2015, Oncotarget.
[18] F. Uckun,et al. Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. , 2015, Journal of the American Chemical Society.
[19] T. Ono,et al. Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[20] Chen Jiang,et al. Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer. , 2015, Bioconjugate chemistry.
[21] Andrew L. Ferguson,et al. Investigating the optimal size of anticancer nanomedicine , 2014, Proceedings of the National Academy of Sciences.
[22] Chen Jiang,et al. A bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene delivery. , 2014, Molecular pharmaceutics.
[23] P. Forgez,et al. Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice , 2014, PloS one.
[24] S. Ren,et al. Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. , 2014, ACS nano.
[25] F. Kiessling,et al. Multidrug resistance: Physiological principles and nanomedical solutions. , 2013, Advanced drug delivery reviews.
[26] Kinam Park,et al. FRET imaging reveals different cellular entry routes of self-assembled and disulfide bonded polymeric micelles. , 2013, Molecular pharmaceutics.
[27] J. Trédaniel,et al. Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy , 2013, Front. Endocrin..
[28] Kinam Park,et al. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging , 2008, Proceedings of the National Academy of Sciences.
[29] Ernst Wagner,et al. Programmed drug delivery: nanosystems for tumor targeting , 2007, Expert opinion on biological therapy.
[30] Jianjun Cheng,et al. Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice , 2006, Cancer Chemotherapy and Pharmacology.
[31] P. Forgez,et al. Neurotensin counteracts apoptosis in breast cancer cells. , 2002, Biochemical and biophysical research communications.
[32] P. Cresswell,et al. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[34] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[35] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.